Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor
Intuitive Ventures announced key leadership appointments to scale its investment platform in minimally invasive care. Terri Burke, former head of medtech investments at Epidarex Capital, joins as Senior Partner, while Dr. Ross Jaffe, co-founder of Versant Ventures, joins as Venture Advisor.
Burke brings over two decades of medtech investing and operational experience, including roles as CEO of Protaryx Medical and Vice President at Edwards Lifesciences (EW). Dr. Jaffe contributes extensive experience in medical devices, diagnostics, and venture firm management from his roles at Versant Ventures and Brentwood Venture Capital.
Intuitive Ventures, managing over $250 million in assets, has backed 13 startups since 2020. The firm recently announced its $150 million Fund II, focusing on healthcare access, precision diagnostics, and leveraging healthcare data for minimally invasive care.
Intuitive Ventures ha annunciato importanti nomine dirigenziali per espandere la sua piattaforma di investimento nella cura minimamente invasiva. Terri Burke, ex responsabile degli investimenti in medtech presso Epidarex Capital, entra come Partner Senior, mentre Dr. Ross Jaffe, co-fondatore di Versant Ventures, si unisce come Consulente di Venture.
Burke porta con sé oltre due decenni di esperienza negli investimenti in medtech e operazioni, inclusi ruoli come CEO di Protaryx Medical e Vice Presidente presso Edwards Lifesciences (EW). Il Dr. Jaffe contribuisce con una vasta esperienza in dispositivi medici, diagnostica e gestione di società di venture dai suoi ruoli in Versant Ventures e Brentwood Venture Capital.
Intuitive Ventures, che gestisce oltre $250 milioni in attivi, ha sostenuto 13 startup dal 2020. La società ha recentemente annunciato il suo $150 milioni Fund II, focalizzandosi sull'accesso alla sanità, diagnosi di precisione e sfruttamento dei dati sanitari per cure minimamente invasive.
Intuitive Ventures anunció nombramientos clave en su liderazgo para escalar su plataforma de inversión en atención mínimamente invasiva. Terri Burke, ex jefa de inversiones en medtech en Epidarex Capital, se une como Socia Senior, mientras que Dr. Ross Jaffe, cofundador de Versant Ventures, se incorpora como Asesor de Venture.
Burke aporta más de dos décadas de experiencia en inversiones y operaciones en medtech, incluidos roles como CEO de Protaryx Medical y Vicepresidenta en Edwards Lifesciences (EW). El Dr. Jaffe contribuye con una amplia experiencia en dispositivos médicos, diagnósticos y gestión de empresas de capital de riesgo a partir de sus roles en Versant Ventures y Brentwood Venture Capital.
Intuitive Ventures, que gestiona más de $250 millones en activos, ha respaldado a 13 startups desde 2020. La firma anunció recientemente su $150 millones Fund II, centrado en el acceso a la salud, diagnósticos de precisión y aprovechamiento de datos de salud para atención mínimamente invasiva.
Intuitive Ventures는 최소 침습 치료 분야에서 투자 플랫폼을 확장하기 위한 주요 리더십 인사를 발표했습니다. Terri Burke는 Epidarex Capital의 메드테크 투자 책임자 출신으로 시니어 파트너로 합류하며, Dr. Ross Jaffe는 Versant Ventures의 공동 창립자로 벤처 어드바이저로 합류합니다.
Burke는 Protaryx Medical의 CEO와 Edwards Lifesciences (EW)의 부사장 역할을 포함하여 20년 이상의 메드테크 투자 및 운영 경험을 가지고 있습니다. Dr. Jaffe는 Versant Ventures와 Brentwood Venture Capital에서의 역할을 통해 의료기기, 진단 및 벤처 회사 관리에 대한 광범위한 경험을 제공합니다.
Intuitive Ventures는 $250 백만 이상의 자산을 관리하며 2020년 이후 13개의 스타트업을 지원했습니다. 이 회사는 최근 $150 백만 Fund II를 발표하며, 의료 접근성, 정밀 진단 및 최소 침습 치료를 위한 의료 데이터 활용에 중점을 두고 있습니다.
Intuitive Ventures a annoncé des nominations clés au sein de sa direction pour développer sa plateforme d'investissement dans les soins minimement invasifs. Terri Burke, ancienne responsable des investissements en medtech chez Epidarex Capital, rejoint en tant que Partenaire Senior, tandis que Dr. Ross Jaffe, co-fondateur de Versant Ventures, rejoint en tant que Conseiller en Venture.
Burke apporte plus de deux décennies d'expérience dans les investissements et les opérations en medtech, y compris des postes de PDG chez Protaryx Medical et de Vice-Présidente chez Edwards Lifesciences (EW). Le Dr Jaffe contribue avec une vaste expérience dans les dispositifs médicaux, le diagnostic et la gestion de sociétés de capital-risque grâce à ses rôles chez Versant Ventures et Brentwood Venture Capital.
Intuitive Ventures, qui gère plus de $250 millions d'actifs, a soutenu 13 startups depuis 2020. La société a récemment annoncé son $150 millions Fund II, axé sur l'accès aux soins de santé, le diagnostic de précision et l'exploitation des données de santé pour des soins minimement invasifs.
Intuitive Ventures hat wichtige Führungspositionen angekündigt, um seine Investitionsplattform im Bereich der minimalinvasiven Versorgung auszubauen. Terri Burke, ehemalige Leiterin der Medizintechnik-Investitionen bei Epidarex Capital, tritt als Senior Partnerin bei, während Dr. Ross Jaffe, Mitgründer von Versant Ventures, als Venture Advisor hinzukommt.
Burke bringt über zwei Jahrzehnte Erfahrung in der Medizintechnik-Investition und -Betrieb mit, darunter Positionen als CEO von Protaryx Medical und Vizepräsidentin bei Edwards Lifesciences (EW). Dr. Jaffe verfügt über umfangreiche Erfahrung in medizinischen Geräten, Diagnostik und im Management von Risikokapitalgesellschaften aus seinen Tätigkeiten bei Versant Ventures und Brentwood Venture Capital.
Intuitive Ventures verwaltet über $250 Millionen an Vermögenswerten und hat seit 2020 13 Startups unterstützt. Das Unternehmen hat kürzlich seinen $150 Millionen Fund II angekündigt, der sich auf den Zugang zur Gesundheitsversorgung, präzise Diagnosen und die Nutzung von Gesundheitsdaten für minimalinvasive Behandlungen konzentriert.
- New Fund II of $150M launched in 2024
- Significant AUM of $250M+
- Successful track record with 13 startup investments since 2020
- Strategic leadership appointments with extensive industry experience
- None.
With more than two decades of medtech investing and operational leadership experience, Burke will help support the growth of the firm’s investment platform. With over
“I am excited to have Terri join the team,” said Murielle Thinard McLane, President and Managing Partner at Intuitive Ventures. “She brings extensive experience as a medtech institutional investor and hands-on operator at both public companies and early-stage start-ups.”
Most recently, Burke was a Venture Partner and Head of Medtech Investments at Epidarex Capital, where she led the firm’s Fund III US/
Burke is currently a board advisor for Raydiant Oximetry, a Trustee for the Roessler-Chadwick Foundation where she also serves as Chair of the Finance Committee and member of the Executive Committee, and a Director for the Roessler-Chadwick Foundation Group.
“Throughout my career, I’ve had the opportunity to position and launch products, acquire technologies and companies, fund start-up companies and raise capital for my own company – working on every side and at every stage of the entrepreneurial journey,” said Burke. “I’m eager to join the team as Intuitive Ventures continues to scale its impact across the global medtech and digital health markets. I also look forward to actively collaborating with the firm’s portfolio companies to support groundbreaking innovations for significant unmet clinical needs.”
In addition to the appointment of Burke, Intuitive Ventures recently welcomed Dr. Ross Jaffe as a Venture Advisor. Dr. Jaffe brings extensive experience in medical devices, diagnostics/monitoring, drug delivery, healthcare software, and venture firm management to his role advising Intuitive Ventures.
Dr. Jaffe was one of the founders of Versant Ventures, where he remains a Legacy Managing Director, and was previously a General Partner at Brentwood Venture Capital, where he started his career as one of the first physicians in the venture capital industry. After stepping back from active investing for Versant, Dr. Jaffe also served as a Venture Advisor for New Enterprise Associates. He is currently a co-founder and Board Chair of Faro Health, an innovative clinical trial software company.
Since its launch in 2020, Intuitive Ventures has backed 13 transformative startups working to fulfill major unmet patient needs. In 2024, the firm announced its
About Intuitive Ventures
Intuitive Ventures invests in companies reimagining the future of minimally invasive care. Our global focus spans diagnostics, MedTech, therapies, and digital health. With
View source version on businesswire.com: https://www.businesswire.com/news/home/20250306137039/en/
Media Contact
Julie Bishop
julie@walkercomms.com
Source: Intuitive Ventures
FAQ
What is the size of Intuitive Ventures' Fund II announced in 2024?
How many startups has Intuitive Ventures backed since its 2020 launch?
What is Terri Burke's background with Edwards Lifesciences (EW)?
What are the three core investment areas for Intuitive Ventures' Fund II?
